Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Carrasco

Showing results (261-270 of 271) with videos related to

Pageof 28
Sort By:
NAR Cancer|June 25, 2026
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancerLee J Pribyl, Jennifer E Kay, Joshua J Corrigan, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancerLee J Pribyl, Jennifer E Kay, Joshua J Corrigan, et al.
Semergen|February 19, 2022
Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping reviewA Ruiz-García, V Pallarés-Carratalá, A Serrano-Cumplido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2021
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARLM Martin, C Zielinski, M Ruiz-Borrego, et al.
Psycho-Oncology|March 3, 2018
Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across SpainI Esteban, M Vilaró, E Adrover, et al.
ESMO Open|November 14, 2021
Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancerM Condorelli, M Bruzzone, M Ceppi, et al.
ESMO Open|September 17, 2024
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histologyE Agostinetto, M Bruzzone, A-S Hamy, et al.
British Journal of Cancer|August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancerA Prat, A Lluch, J Albanell, et al.
ESMO Open|August 14, 2025
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriersM Perachino, E Blondeaux, V Delucchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2024
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriersL Arecco, M Bruzzone, R Bas, et al.
Pageof 28

Showing results (261-270 of 271) with videos related to

Sort By:
Pageof 28
NAR Cancer|June 25, 2026
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancerLee J Pribyl, Jennifer E Kay, Joshua J Corrigan, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancerLee J Pribyl, Jennifer E Kay, Joshua J Corrigan, et al.
Semergen|February 19, 2022
Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping reviewA Ruiz-García, V Pallarés-Carratalá, A Serrano-Cumplido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2021
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARLM Martin, C Zielinski, M Ruiz-Borrego, et al.
Psycho-Oncology|March 3, 2018
Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across SpainI Esteban, M Vilaró, E Adrover, et al.
ESMO Open|November 14, 2021
Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancerM Condorelli, M Bruzzone, M Ceppi, et al.
ESMO Open|September 17, 2024
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histologyE Agostinetto, M Bruzzone, A-S Hamy, et al.
British Journal of Cancer|August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancerA Prat, A Lluch, J Albanell, et al.
ESMO Open|August 14, 2025
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriersM Perachino, E Blondeaux, V Delucchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2024
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriersL Arecco, M Bruzzone, R Bas, et al.
Pageof 28